Vikram Kesavabhotla
Stock Analyst at Baird
(3.77)
# 767
Out of 4,711 analysts
43
Total ratings
58.06%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Vikram Kesavabhotla
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDDY GoDaddy | Maintains: Outperform | $200 → $225 | $205.41 | +9.54% | 8 | Nov 19, 2024 | |
| ROKU Roku, Inc. | Upgrades: Outperform | $70 → $90 | $80.59 | +11.68% | 3 | Nov 18, 2024 | |
| TTD The Trade Desk | Maintains: Outperform | $130 → $140 | $125.01 | +11.99% | 3 | Nov 8, 2024 | |
| DOCS Doximity | Maintains: Outperform | $41 → $45 | $57.83 | -22.19% | 3 | Sep 17, 2024 | |
| DH Definitive Healthcare | Maintains: Neutral | $6 → $5 | $4.18 | +19.62% | 4 | Aug 7, 2024 | |
| DV DoubleVerify Holdings | Maintains: Outperform | $42 → $34 | $19.96 | +70.34% | 3 | May 8, 2024 | |
| SPOT Spotify Technology | Maintains: Outperform | $185 → $225 | $460.88 | -51.18% | 2 | Dec 8, 2023 | |
| IAS Integral Ad Science Holding | Initiates: Outperform | $19 | $10.44 | +81.99% | 1 | Aug 18, 2023 | |
| NFLX Netflix | Upgrades: Outperform | $340 → $500 | $909.05 | -45.00% | 1 | Jul 24, 2023 | |
| HIMS Hims & Hers Health | Initiates: Neutral | $10 | $26.20 | -61.83% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $50 | $33.76 | +48.10% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $23 | $7.75 | +196.77% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.44 | +35.14% | 4 | Jun 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $5 | $4.19 | +19.33% | 2 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $2.98 | +0.67% | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $58 → $54 | $3.48 | +1,451.72% | 2 | Sep 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $10.71 | +180.11% | 1 | Jul 23, 2021 |
GoDaddy
Nov 19, 2024
Maintains: Outperform
Price Target: $200 → $225
Current: $205.41
Upside: +9.54%
Roku, Inc.
Nov 18, 2024
Upgrades: Outperform
Price Target: $70 → $90
Current: $80.59
Upside: +11.68%
The Trade Desk
Nov 8, 2024
Maintains: Outperform
Price Target: $130 → $140
Current: $125.01
Upside: +11.99%
Doximity
Sep 17, 2024
Maintains: Outperform
Price Target: $41 → $45
Current: $57.83
Upside: -22.19%
Definitive Healthcare
Aug 7, 2024
Maintains: Neutral
Price Target: $6 → $5
Current: $4.18
Upside: +19.62%
DoubleVerify Holdings
May 8, 2024
Maintains: Outperform
Price Target: $42 → $34
Current: $19.96
Upside: +70.34%
Spotify Technology
Dec 8, 2023
Maintains: Outperform
Price Target: $185 → $225
Current: $460.88
Upside: -51.18%
Integral Ad Science Holding
Aug 18, 2023
Initiates: Outperform
Price Target: $19
Current: $10.44
Upside: +81.99%
Netflix
Jul 24, 2023
Upgrades: Outperform
Price Target: $340 → $500
Current: $909.05
Upside: -45.00%
Hims & Hers Health
Apr 11, 2023
Initiates: Neutral
Price Target: $10
Current: $26.20
Upside: -61.83%
Apr 11, 2023
Initiates: Outperform
Price Target: $50
Current: $33.76
Upside: +48.10%
Apr 11, 2023
Initiates: Outperform
Price Target: $23
Current: $7.75
Upside: +196.77%
Jun 22, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.44
Upside: +35.14%
May 16, 2022
Downgrades: Neutral
Price Target: $6 → $5
Current: $4.19
Upside: +19.33%
Nov 16, 2021
Downgrades: Neutral
Price Target: $10 → $3
Current: $2.98
Upside: +0.67%
Sep 17, 2021
Upgrades: Outperform
Price Target: $58 → $54
Current: $3.48
Upside: +1,451.72%
Jul 23, 2021
Initiates: Outperform
Price Target: $30
Current: $10.71
Upside: +180.11%